ProMIS Neurosciences Announces 1-for-25 Reverse Stock Split Effective November 28, 2025

ProMIS Neurosciences Inc.

Reverse stock split at ratio 1:25 approved by board on Nov 17, 2025, effective Nov 28, 2025.
Outstanding shares will reduce from approximately 53.8 million to approximately 2.15 million.
Nasdaq deficiency notice received Jan 8, 2025 for bid price below $1.00; reverse split aims to cure compliance.
Proportional adjustments to equity incentive plans, stock options, and warrants.
No fractional shares issued; stockholders receive cash in lieu of fractional shares.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ProMIS Neurosciences Inc.: Reverse stock split at a 1-for-25 ratio effected via articles of amendment (effective 2025-11-28).

Change: charter amendment
Effective: 2025-11-28

Exact text from the filing

Effective as of 12:01 a.m. Eastern Time on November 28, 2025, the Company filed the Articles Amendment to effect one-for-twenty-five reverse stock split

View on SEC.gov

241 governance changes filed in the last 30 days. Browse all governance changes →

ProMIS Neurosciences Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-115182

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.